Ocutrx™ review of public statements and products OcuLen™ OR-Bot™ CamTrx™ MiniLenz™ StereoLenz™ ORLenz™ ScopeTrx™
  • Stock
  • FAQ
  • Product Reviews
  • Product Comparisons
  • Press Releases
  • Team Bio's
  • Technology
contact
contact
  • Comparisons
    • Oculenz vs Acesight
    • Oculenz vs Esight
    • Oculenz vs Eyedaptic
    • Oculenz vs Hololens
    • Oculenz vs Irisvision
    • Oculenz vs Magic Leap 2
    • Oculenz vs NuEyes
    • Oculenz vs Orcam
    • Oculenz vs Oxsight
  • Ocutrx-products
    • CamTrx™
    • EyeAlinz™
    • MiniLenz™
    • OcuLenz™
    • OR-Bot™
    • ORLenz™
    • ScopeTrx™
    • StereoLenz™
  • Ocutrx-team-leaders
    • Ben Rafiee - Ocutrx Chief Mechanical Engineer
    • Jim Gatzimas - Ocutrx Chief Commercial Officer
    • John H Bluher JD - Ocutrx Director of Finance
    • Jordan L Boss - Ocutrx Chief Product Engineer
    • Kevin Griffin - Ocutrx Chief Financial Officer
    • Linda Lam - Ocutrx Chief Scientific and Strategy Officer
    • Marc Stenzel - Ocutrx Low Vision Sales
    • Mary E. Van Orman, JD - Ocutrx Chief Compliance Officer
    • Michael H. Freeman
    • Mitch C Freeman - Ocutrx Chief Operating Officer
    • Montgomery Freeman - Ocutrx Chief Marketing Officer
    • Simon Prosser - Ocutrx Global Director of Surgical Applications
    • Steven Von der Porten - Ocutrx Senior Optical Engineer
    • Victoria Marie McArtor - Ocutrx Chief Communications Officer
  • Ocutrx-technologies
    • ACUSTRX™ Sound
    • ASSISTRX™ Visual Virtual Assistant
    • DIGITRX™ Hand Gesturing and Control
    • Dynamic Opacity™
    • DYNATRX™ OVERLAY SYSTEM
    • EYETRX™ EYE-TRACKING
    • FONTRX™ Cell Phone
    • Myctrx™ Microphone Features
    • OPTRX™ Dynamic Opacity
    • SLAMTRX™ Mapping
    • Syntrx™
    • VOICTRX™ Speech Recognition and Voice Command
  • Press-releases
    • First Medical Patent Issues for the Oculenz™ Augmented Reality Glasses
    • Dr. Thomas A. Finley, M.D. Appointed as Chairmen of Ocutrx International Medical Advisory Board
    • Ocutrx Vision Technologies Appoints Dr. Linda Lam as Chief Scientific and Strategy Officer
    • Ocutrx Vision Technologies Named to StartUp City's List of 15 Most Promising Wearable Technology Startups
    • Ocutrx Vision Technologies Unveils Groundbreaking Oculenz AR Cellular with Eye-Tracking Glasses
    • Ocutrx Vision Technologies Receives Second Patent for Augmented Reality Glasses Eye Tracking Technology
    • Ocutrx Sets the Pace for AR Medical Device Technology at Third Annual Medical Devices Innovation Conference
    • Groundbreaking Pre-Pilot Clinical Trial from Ocutrx Vision Technologies Yields Exciting Results for Patients with AMD
    • California Tech Startup Ocutrx Vision Technologies Steals the Show at Prestigious Retina Conference
    • Ocutrx Unveils ORLenz for Surgery Visualization Technology in AR Wear Headset
    • Ocutrx Vision Technologies COO Details Impact of Wearables on the Healthcare Industry at Medical Design & Manufacturing West Conference
    • Ocutrx Vision Technologies Reports Successful Preliminary Test Results with its Dynamic Opacity in Medical Laser Safety
    • Ocutrx Appoints Dr. Daniel Ting to International Medical and Scientific Advisory Boards as Company Eyes Expansion into Medical Data, Telemedicine and AI Tech
    • Ocutrx Executive to Lead Augmented Reality Session in Global E-Conference on Ophthalmology
    • Ocutrx’s Oculenz Advances from AR Headset to Full Surgery Visualization Theatre
    • Ocutrx Vision Technologies Appoints Three New Directors, Adds Colorado Testing Facility, Offices in Northern and Southern California
    • Ocutrx Vision Technologies Selects Karten Design to Refine the Final Oculenz AR Headset Design for Commercialization
    • Ocutrx Vision Technologies Will Deliver World’s First 5G AR/XR Medical Specific Platform in 2021
    • Ocutrx Vision Technologies Named a Finalist for OCTANe’s High Tech Awards
    • Ocutrx Vision Technologies CEO to Discuss The Future of Medical Technology at Precision In Medical Devices Virtual Summit
    • Ocutrx Vision Technologies Continues to Innovate in the AR Industry and is Granted Third & Fourth Patents for Visual Field Testing & Dynamic Opacity™ Technology
    • Ocutrx Technologies Appoints Dr. Bill Link as Chairman of the Ocutrx International Scientific Advisory Board
    • Ocutrx Technologies Adds to its Surgical Visualization Suite with Scopetrx™ a Wireless Laparoscopic Swivel Camera
    • Ocutrx Continues to Modernize the Medical Telehealth Industry with Fifth Patent for In-home Visual Field Test Monitoring and Alerting
    • Ocutrx Technologies Leads the Field With Three Patents On Near-eye Pupil-forming Catadioptric Optical Engine

Ocutrx-technologies

  • Ocutrx-technologies
    • ACUSTRX™ Sound
    • ASSISTRX™ Visual Virtual Assistant
    • DIGITRX™ Hand Gesturing and Control
    • Dynamic Opacity™
    • DYNATRX™ OVERLAY SYSTEM
    • EYETRX™ EYE-TRACKING
    • FONTRX™ Cell Phone
    • Myctrx™ Microphone Features
    • OPTRX™ Dynamic Opacity
    • SLAMTRX™ Mapping
    • Syntrx™
    • VOICTRX™ Speech Recognition and Voice Command
  • Victoria Marie McArtor - Ocutrx Chief Communications Officer ACUSTRX™ Sound
      Ocutrx™ review of public statements and products OcuLen™ OR-Bot™ CamTrx™ MiniLenz™ StereoLenz™ ORLenz™ ScopeTrx™
        Designed by people that care. All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names,trademarks and brands does not imply endorsement.